These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6438492)

  • 1. [Study of trypsin-substrate and trypsin-inhibitor complexes. 1. Conformation of Asp-102, His-57 and Ser-195 residues in the trypsin active center].
    Godzhaev NM
    Mol Biol (Mosk); 1984; 18(5):1432-5. PubMed ID: 6438492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Conformational aspects of beta-trypsin interaction with substrates and pancreatic trypsin inhibitor. I. Conformational properties of residues in the enzyme-active center and the structure of a non-valent enzyme-substrate complex].
    Godzhaev NM; Aliev RE; Popov EM
    Mol Biol (Mosk); 1986; 20(1):102-19. PubMed ID: 3951435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Asp102 in the catalytic relay system of serine proteases: a theoretical study.
    Ishida T; Kato S
    J Am Chem Soc; 2004 Jun; 126(22):7111-8. PubMed ID: 15174882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. X-ray crystallographic analyses of complexes between bovine beta-trypsin and Schiff base copper(II) or iron(III) chelates.
    Toyota E; Ng KK; Sekizaki H; Itoh K; Tanizawa K; James MN
    J Mol Biol; 2001 Jan; 305(3):471-9. PubMed ID: 11152605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the complex of trypsin with a highly potent synthetic inhibitor at 0.97 A resolution.
    Sherawat M; Kaur P; Perbandt M; Betzel C; Slusarchyk WA; Bisacchi GS; Chang C; Jacobson BL; Einspahr HM; Singh TP
    Acta Crystallogr D Biol Crystallogr; 2007 Apr; 63(Pt 4):500-7. PubMed ID: 17372355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Properties of the His57-Asp102 dyad of rat trypsin D189S in the zymogen, activated enzyme, and alpha1-proteinase inhibitor complexed forms.
    Kaslik G; Westler WM; Gráf L; Markley JL
    Arch Biochem Biophys; 1999 Feb; 362(2):254-64. PubMed ID: 9989934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure of a feruloyl esterase from Aspergillus niger.
    McAuley KE; Svendsen A; Patkar SA; Wilson KS
    Acta Crystallogr D Biol Crystallogr; 2004 May; 60(Pt 5):878-87. PubMed ID: 15103133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity and specificity of serine endopeptidase-protein inhibitor interactions. Empirical free energy calculations based on X-ray crystallographic structures.
    Krystek S; Stouch T; Novotny J
    J Mol Biol; 1993 Dec; 234(3):661-79. PubMed ID: 8254666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-barrier hydrogen bond hypothesis in the catalytic triad residue of serine proteases: correlation between structural rearrangement and chemical shifts in the acylation process.
    Ishida T
    Biochemistry; 2006 May; 45(17):5413-20. PubMed ID: 16634622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A theoretical study of the active sites of papain and S195C rat trypsin: implications for the low reactivity of mutant serine proteinases.
    Beveridge AJ
    Protein Sci; 1996 Jul; 5(7):1355-65. PubMed ID: 8819168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The mobility of the side chains of His57 and other amino acid residues in the active center of chymotrypsin].
    Kostetskiĭ PV
    Biofizika; 2004; 49(4):595-600. PubMed ID: 15458241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mechanism of action of aspartic proteinases. V. Conformational characteristics of fragments of substrate-binding sites in rhizopuspepsin and HIV-1 proteinase].
    Kashparov IV; Popov ME; Rumsh LD; Popov EM
    Bioorg Khim; 1999 Aug; 25(8):597-602. PubMed ID: 10578465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The 0.83 A resolution crystal structure of alpha-lytic protease reveals the detailed structure of the active site and identifies a source of conformational strain.
    Fuhrmann CN; Kelch BA; Ota N; Agard DA
    J Mol Biol; 2004 May; 338(5):999-1013. PubMed ID: 15111063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Introduction of alpha-hydroxymethyamino acid residues in substrate specificity P1 position of trypsin inhibitor SFTI-1 from sunflower seeds retains its activity.
    Zabłotna E; Kret A; Jaśkiewicz A; Olma A; Leplawy MT; Rolka K
    Biochem Biophys Res Commun; 2006 Feb; 340(3):823-8. PubMed ID: 16380077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Conformational aspects of beta-trypsin interaction with substrates and pancreatic trypsin inhibitor. III. Catalytic act of trypsin and its inhibition].
    Popov EM; Godzhaev NM; Aliev RE
    Mol Biol (Mosk); 1986; 20(2):357-68. PubMed ID: 3702867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A structural model for the prostate disease marker, human prostate-specific antigen.
    Villoutreix BO; Getzoff ED; Griffin JH
    Protein Sci; 1994 Nov; 3(11):2033-44. PubMed ID: 7535613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of noncovalent trypsin inhibitor based on the X-ray crystal structure of the complex.
    Nakamura M; Tomoo K; Ishida T; Taguchi H; Tsuda Y; Okada Y; Okunomiya A; Wanaka K; Okamoto S
    Biochem Biophys Res Commun; 1995 Aug; 213(2):583-7. PubMed ID: 7646515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of bovine duodenase, a serine protease, with dual trypsin and chymotrypsin-like specificities.
    Pletnev VZ; Zamolodchikova TS; Pangborn WA; Duax WL
    Proteins; 2000 Oct; 41(1):8-16. PubMed ID: 10944388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Subangstrom crystallography reveals that short ionic hydrogen bonds, and not a His-Asp low-barrier hydrogen bond, stabilize the transition state in serine protease catalysis.
    Fuhrmann CN; Daugherty MD; Agard DA
    J Am Chem Soc; 2006 Jul; 128(28):9086-102. PubMed ID: 16834383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.